ROS‐Responsive Hydrogel Delivery of miR‐665 for Alopecia Areata: Mechanistic Insights and Translational Perspectives
Advanced Biology · 2026-11 · 10 (11)
DOI: 10.1002/adbi.70169 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Biology, online erschienen am 04.11.2026. Verfasst von Wenjing Cheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology, Shanghai, China. Hauptthemen laut MEDLINE: MicroRNAs, Alopecia Areata, Reactive Oxygen Species, Hydrogels. Die Arbeit nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Alopecia areata (AA) is a common autoimmune hair‐loss disorder driven by cytotoxic T cells, interferon‐γ (IFN‐γ) signaling, and dysregulated JAK‐STAT activation. Current systemic treatments, including JAK inhibitors, are limited by safety considerations and frequent relapse after treatment discontinuation. Local nucleic acid delivery is promising but faces challenges in stability, tissue retention, and controlled release. Luo et al. recently developed a reactive oxygen species (ROS)‐responsive injectable hydrogel based on polyvinyl alcohol crosslinked with N 1 ,N 3 ‐bis(4‐boronobenzyl)‐N 1 ,N 1 ,N 3 ,N 3 ‐tetramethylpropane‐1,3‐diaminium bromide (PVA‐TSPBA) for delivery of miR‐665, a microRNA targeting STAT3. This Commentary evaluates the mechanistic rationale of the miR‐665/STAT3 axis, the advantages of ROS‐responsive hydrogels for lesion‐specific release, and key translational barriers. Specific testable mechanisms are proposed for the dissociation between reduced STAT3 mRNA and stable total protein, including upstream kinases (JAK2/SRC), phosphatases (SHP‐1/PTEN), and indirect pathways. Although the system shows prolonged local retention, attenuated inflammation, and enhanced hair follicle regeneration in preclinical models, critical issues remain unresolved, including the cellular targeting spectrum of miR‐665, in vivo ROS‐dependent release kinetics, miRNA stability under oxidative conditions, and potential systemic immune effects. Single‐cell omics, spatial imaging, in vivo imaging, humanized models, and toxicological evaluation will be key to clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology, Shanghai, China.
- Department of Histology and Embryology, Basic Medical College, Naval Medical University, Shanghai, China.
- Brigade One Team, Basic Medical College, Naval Medical University, Shanghai, China.
- Department of Stem Cells and Regenerative Medicine, Center For Translational Medicine, Naval Medical University, Shanghai, China.
ORCID-Profile: Minjuan Wu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Cheng, W., Ren, X., Chen, G., Ni, S., Ni, H., & Wu, M. (2026). ROS‐Responsive Hydrogel Delivery of miR‐665 for Alopecia Areata: Mechanistic Insights and Translational Perspectives. Advanced Biology, 10(11). https://doi.org/10.1002/adbi.70169
Vancouver
Cheng W, Ren X, Chen G, Ni S, Ni H, Wu M. ROS‐Responsive Hydrogel Delivery of miR‐665 for Alopecia Areata: Mechanistic Insights and Translational Perspectives. Advanced Biology. 2026;10(11). doi:10.1002/adbi.70169
BibTeX
@article{Cheng2026,
author = {Cheng, Wenjing and Ren, Xiaoran and Chen, Guodong and Ni, Sijia and Ni, Haitao and Wu, Minjuan},
title = {ROS‐Responsive Hydrogel Delivery of miR‐665 for Alopecia Areata: Mechanistic Insights and Translational Perspectives},
journal = {Advanced Biology},
year = {2026},
volume = {10},
number = {11},
doi = {10.1002/adbi.70169}
}
EUVIMED